1 | Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines | Coautor: Chavez-Dominguez R., Perez-Medina M., Lopez-Gonzalez J.S., Benito-Lopez J.J., et al. | 2024 | Cancers | WoS-id: 001268059700001 Scopus-id: 2-s2.0-85198348092
| 0 | 0 |
2 | SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung Adenocarcinoma | Coautor: Chavez-Dominguez, R, Marroquin-Muciño, M, Benito-Lopez, JJ, Perez-Medina, M, et al. | 2024 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | WoS-id: 001365447600001 Scopus-id: 2-s2.0-85210429639
| 0 | 0 |
3 | Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma | 1ᵉʳ autor: Chavez-Dominguez, Rodolfo, Aguilar-Cazares, Dolores, Perez-Medina, Mario, Avila-Rios, Santiago, et al. | 2023 | Frontiers in Oncology | WoS-id: 001093783900001 Scopus-id: 2-s2.0-85175574593
| 5 | 5 |
4 | The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment | 2ᵒ autor: Chavez-Dominguez, Rodolfo, Aguilar-Cazares, Dolores, Marroquin-Mucino, Mario, Perez-Medina, Mario, et al. | 2022 | Frontiers in Endocrinology | WoS-id: 000861381500001 Scopus-id: 2-s2.0-85137822673
| 32 | 33 |
5 | Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines | 1ᵉʳ autor: Chavez-Dominguez, Rodolfo L., Perez-Medina, Mario A., Lopez-Gonzalez, Jose S., Galicia-Velasco, Miriam, et al. | 2021 | Frontiers in Oncology | WoS-id: 000735711800001 Scopus-id: 2-s2.0-85121807878
| 8 | 8 |
6 | The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity | 1ᵉʳ autor: Chavez-Dominguez, Rodolfo, Perez-Medina, Mario, Lopez-Gonzalez, Jose S., Galicia-Velasco, Miriam, et al. | 2020 | Frontiers in Oncology | WoS-id: 000579853600001 Scopus-id: 2-s2.0-85093819946
| 219 | 230 |
7 | Contribution of Angiogenesis to Inflammation and Cancer | 2ᵒ autor: Chavez-Dominguez, Rodolfo, Aguilar-Cazares, Dolores, Carlos-Reyes, Angeles, Lopez-Camarillo, Cesar, et al. | 2019 | Frontiers in Oncology | WoS-id: 000504732300001 Scopus-id: 2-s2.0-85077273829
| 238 | 251 |